More Than 700 People on ADAP Waiting Lists; Program Needs $214 Million in New Funding, Advocates Say
September 5, 2003
At least 700 HIV-positive people in the United States are on waiting lists to receive antiretroviral drugs from AIDS Drug Assistance Programs, and two people have died while waiting for the drugs, the Charleston Gazette reports (Heys, Charleston Gazette, 9/3). The federal-state ADAP program provides free or low-cost medication to low-income HIV-positive individuals who do not qualify for Medicaid or other drug assistance programs. Many state ADAPs are experiencing financial trouble due to high demand for the drugs, soaring prescription costs and state budget shortfalls. Fifteen states currently have waiting lists or access restrictions on their ADAPs, and four more states anticipate having to impose new or additional restrictions on their programs in fiscal year 2003 (Kaiser Daily HIV/AIDS Report, 8/29). Federal funding for ADAP has increased from $52 million in 1996 to $639 million last year, and during that time, the number of people using the programs rose 154% and monthly drug costs increased by 370% (Charleston Gazette, 9/3).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.